Colony Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,515
Closed -$321K 816
2022
Q2
$321K Buy
9,515
+202
+2% +$7.08K 0.01% 676
2022
Q1
$325K Buy
9,313
+455
+5% +$15.6K ﹤0.01% 706
2021
Q4
$270K Sell
8,858
-15,968
-64% -$520K ﹤0.01% 720
2021
Q3
$814K Sell
24,826
-10,787
-30% -$345K 0.02% 463
2021
Q2
$1.08M Buy
+35,613
New +$1.17M 0.02% 378

Other funds holding OGN

Colony Group's OGN Position: Q3 2022 in Review

Colony Group sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 9,515 shares — an estimated $321K sold.

Colony Group first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $1.08M in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Colony Group reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Colony Group sold 9,515 Organon & Co shares in Q3 2022, an estimated $321K.
  • Colony Group first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Colony Group's Organon & Co position peaked at $1.08M in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Colony Group's 13F filing for Q3 2022, filed 15 Nov 2022.